• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ERK3/MAPK6 决定 CDC42/RAC1 的活性和 ARP2/3 依赖的肌动蛋白聚合。

ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization.

机构信息

Cell Biology Unit, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Departments of Biology and Physics, Wilkes University, Wilkes Barre, United States.

出版信息

Elife. 2023 Apr 14;12:e85167. doi: 10.7554/eLife.85167.

DOI:10.7554/eLife.85167
PMID:37057894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10191626/
Abstract

The actin cytoskeleton is tightly controlled by RhoGTPases, actin binding-proteins and nucleation-promoting factors to perform fundamental cellular functions. We have previously shown that ERK3, an atypical MAPK, controls IL-8 production and chemotaxis (Bogueka et al., 2020). Here, we show in human cells that ERK3 directly acts as a guanine nucleotide exchange factor for CDC42 and phosphorylates the ARP3 subunit of the ARP2/3 complex at S418 to promote filopodia formation and actin polymerization, respectively. Consistently, depletion of ERK3 prevented both basal and EGF-dependent RAC1 and CDC42 activation, maintenance of F-actin content, filopodia formation, and epithelial cell migration. Further, ERK3 protein bound directly to the purified ARP2/3 complex and augmented polymerization of actin in vitro. ERK3 kinase activity was required for the formation of actin-rich protrusions in mammalian cells. These findings unveil a fundamentally unique pathway employed by cells to control actin-dependent cellular functions.

摘要

细胞骨架肌动蛋白被 RhoGTPases、肌动蛋白结合蛋白和核形成促进因子严密调控,以执行基本的细胞功能。我们之前已经表明,ERK3(一种非典型的 MAPK)控制着 IL-8 的产生和趋化作用(Bogueka 等人,2020 年)。在这里,我们在人类细胞中表明,ERK3 直接作为 CDC42 的鸟嘌呤核苷酸交换因子,并磷酸化 ARP2/3 复合物的 ARP3 亚基的 S418,分别促进丝状伪足形成和肌动蛋白聚合。一致地,ERK3 的耗竭阻止了基础和 EGF 依赖性 RAC1 和 CDC42 的激活、F-肌动蛋白含量的维持、丝状伪足的形成和上皮细胞的迁移。此外,ERK3 蛋白直接与纯化的 ARP2/3 复合物结合,并增强体外肌动蛋白的聚合。ERK3 激酶活性对于哺乳动物细胞中富含肌动蛋白的突起的形成是必需的。这些发现揭示了细胞用来控制肌动蛋白依赖性细胞功能的一种基本独特途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/f4f0301bed6c/elife-85167-sa2-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/f689af155567/elife-85167-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/c3ffa9b754de/elife-85167-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/d3f388b82364/elife-85167-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/b95322777040/elife-85167-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/d81988649d3c/elife-85167-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/1f8bcf78f1c9/elife-85167-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/939c56947c80/elife-85167-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/d54f4afa966e/elife-85167-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/18f59da6272e/elife-85167-fig2-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/a3141938d57c/elife-85167-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/f94baa66604e/elife-85167-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/4ba1b4a4ad73/elife-85167-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/47683b5fd9bb/elife-85167-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/f8e923996a3d/elife-85167-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/cb205ddb396b/elife-85167-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/843641e7718a/elife-85167-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/bfd9d935e7c8/elife-85167-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/eab805a27a8f/elife-85167-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/64cbc46a18b0/elife-85167-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/bab0f2d83952/elife-85167-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/d0921db4514f/elife-85167-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/1b86799279f5/elife-85167-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/b0542ce99790/elife-85167-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/458c3868e1e2/elife-85167-sa2-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/f4f0301bed6c/elife-85167-sa2-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/f689af155567/elife-85167-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/c3ffa9b754de/elife-85167-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/d3f388b82364/elife-85167-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/b95322777040/elife-85167-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/d81988649d3c/elife-85167-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/1f8bcf78f1c9/elife-85167-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/939c56947c80/elife-85167-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/d54f4afa966e/elife-85167-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/18f59da6272e/elife-85167-fig2-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/a3141938d57c/elife-85167-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/f94baa66604e/elife-85167-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/4ba1b4a4ad73/elife-85167-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/47683b5fd9bb/elife-85167-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/f8e923996a3d/elife-85167-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/cb205ddb396b/elife-85167-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/843641e7718a/elife-85167-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/bfd9d935e7c8/elife-85167-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/eab805a27a8f/elife-85167-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/64cbc46a18b0/elife-85167-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/bab0f2d83952/elife-85167-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/d0921db4514f/elife-85167-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/1b86799279f5/elife-85167-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/b0542ce99790/elife-85167-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/458c3868e1e2/elife-85167-sa2-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c4/10191626/f4f0301bed6c/elife-85167-sa2-fig3.jpg

相似文献

1
ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization.ERK3/MAPK6 决定 CDC42/RAC1 的活性和 ARP2/3 依赖的肌动蛋白聚合。
Elife. 2023 Apr 14;12:e85167. doi: 10.7554/eLife.85167.
2
Interaction between Tiam1 and the Arp2/3 complex links activation of Rac to actin polymerization.Tiam1与Arp2/3复合物之间的相互作用将Rac的激活与肌动蛋白聚合联系起来。
Biochem J. 2006 Jul 1;397(1):39-45. doi: 10.1042/BJ20051957.
3
ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers.ERK3 转录上调由 ∆Np63α 介导,并在非黑素瘤皮肤癌中发挥 ∆Np63α 抑制细胞迁移的作用。
BMC Cancer. 2021 Feb 12;21(1):155. doi: 10.1186/s12885-021-07866-w.
4
ERK3/MAPK6 controls IL-8 production and chemotaxis.ERK3/MAPK6 控制 IL-8 的产生和趋化作用。
Elife. 2020 Apr 21;9:e52511. doi: 10.7554/eLife.52511.
5
The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.C 端尾巴调节 ERK3 激酶活性及其促进癌细胞迁移和侵袭的能力。
Int J Mol Sci. 2020 Jun 5;21(11):4044. doi: 10.3390/ijms21114044.
6
A role for the small GTPase Rac1 in vaccinia actin-based motility.小GTP酶Rac1在痘苗病毒基于肌动蛋白的运动中所起的作用。
Small GTPases. 2014;5(2):e29038. doi: 10.4161/sgtp.29038. Epub 2014 Oct 31.
7
C(16)-Ceramide-induced F-actin regulation stimulates mouse embryonic stem cell migration: involvement of N-WASP/Cdc42/Arp2/3 complex and cofilin-1/α-actinin.C16-神经酰胺诱导的F-肌动蛋白调节刺激小鼠胚胎干细胞迁移:N-WASP/Cdc42/Arp2/3复合物和丝切蛋白-1/α-辅肌动蛋白的参与
Biochim Biophys Acta. 2013 Feb;1831(2):350-60. doi: 10.1016/j.bbalip.2012.09.005. Epub 2012 Sep 15.
8
Involvement of the Rac1-IRSp53-Wave2-Arp2/3 Signaling Pathway in HIV-1 Gag Particle Release in CD4 T Cells.Rac1-IRSp53-Wave2-Arp2/3信号通路参与HIV-1 Gag颗粒在CD4 T细胞中的释放
J Virol. 2015 Aug;89(16):8162-81. doi: 10.1128/JVI.00469-15. Epub 2015 May 27.
9
PLEKHG3 enhances polarized cell migration by activating actin filaments at the cell front.PLEKHG3通过激活细胞前端的肌动蛋白丝来增强极化细胞迁移。
Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10091-6. doi: 10.1073/pnas.1604720113. Epub 2016 Aug 23.
10
A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration.非典型丝裂原活化蛋白激酶ERK3在调节乳腺癌细胞形态和迁移中的新作用。
Cell Adh Migr. 2015;9(6):483-94. doi: 10.1080/19336918.2015.1112485.

引用本文的文献

1
ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity.ERK3/MAPK6通过集体迁移和上皮-间质转化可塑性促进三阴性乳腺癌进展。
Front Oncol. 2025 Aug 27;15:1563969. doi: 10.3389/fonc.2025.1563969. eCollection 2025.
2
Identification of characteristic genes ofanddeficiency constitutions: an integrated analysis based on bioinformatics and machine learning.平和质与偏颇体质特征基因的鉴定:基于生物信息学和机器学习的综合分析
J Tradit Chin Med. 2025 Aug;45(4):909-921. doi: 10.19852/j.cnki.jtcm.2025.04.021.
3
Ethanol Extract Restores MK-801-Induced Cytoskeleton Regulation in Neuro2A and IMR-32 Cells and Locomotor Hyperactivity in C57BL/6 Mice by Modulating the Rho Signaling Pathway.

本文引用的文献

1
ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers.ERK3 转录上调由 ∆Np63α 介导,并在非黑素瘤皮肤癌中发挥 ∆Np63α 抑制细胞迁移的作用。
BMC Cancer. 2021 Feb 12;21(1):155. doi: 10.1186/s12885-021-07866-w.
2
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.KRAS介导的非小细胞肺癌肿瘤发生需要ERK3/MAPK6。
Cancer Gene Ther. 2021 May;28(5):359-374. doi: 10.1038/s41417-020-00245-w. Epub 2020 Oct 17.
3
The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.
乙醇提取物通过调节Rho信号通路恢复MK-801诱导的Neuro2A和IMR-32细胞中的细胞骨架调节以及C57BL/6小鼠的运动性多动。
Curr Issues Mol Biol. 2025 Apr 28;47(5):312. doi: 10.3390/cimb47050312.
4
Akt-phosphorylated UFL1 UFMylates ArpC4 to promote metastasis.Akt磷酸化的UFL1通过对肌动蛋白相关蛋白复合物4(ArpC4)进行泛素样修饰因子1(UFM1)化来促进转移。
Nat Struct Mol Biol. 2025 May 26. doi: 10.1038/s41594-025-01576-8.
5
Clearing Amyloid-Beta by Astrocytes: The Role of Rho GTPases Signaling Pathways as Potential Therapeutic Targets.星形胶质细胞清除β-淀粉样蛋白:Rho GTP酶信号通路作为潜在治疗靶点的作用
Brain Sci. 2024 Dec 10;14(12):1239. doi: 10.3390/brainsci14121239.
6
Rac1 inhibition regenerates wounds in mouse fetuses via altered actin dynamics.Rac1 抑制通过改变肌动蛋白动力学在胎鼠伤口中再生。
Sci Rep. 2024 Nov 8;14(1):27213. doi: 10.1038/s41598-024-78395-2.
7
Identification of metabolic biomarkers in idiopathic pulmonary arterial hypertension using targeted metabolomics and bioinformatics analysis.采用靶向代谢组学和生物信息学分析鉴定特发性肺动脉高压的代谢生物标志物。
Sci Rep. 2024 Oct 25;14(1):25283. doi: 10.1038/s41598-024-76514-7.
8
Atypical MAPKs in cancer.癌症中的非典型丝裂原活化蛋白激酶
FEBS J. 2025 May;292(9):2173-2188. doi: 10.1111/febs.17283. Epub 2024 Sep 30.
9
Aggravated Ulcerative Colitis via circNlgn-Mediated Suppression of Nuclear Actin Polymerization.环状Nlgn介导的核肌动蛋白聚合抑制加重溃疡性结肠炎
Research (Wash D C). 2024 Aug 23;7:0441. doi: 10.34133/research.0441. eCollection 2024.
10
Proangiogenic effect and underlying mechanism of holmium oxide nanoparticles: a new biomaterial for tissue engineering.钬氧化物纳米颗粒的促血管生成作用及其机制:一种用于组织工程的新型生物材料。
J Nanobiotechnology. 2024 Jun 21;22(1):357. doi: 10.1186/s12951-024-02642-x.
C 端尾巴调节 ERK3 激酶活性及其促进癌细胞迁移和侵袭的能力。
Int J Mol Sci. 2020 Jun 5;21(11):4044. doi: 10.3390/ijms21114044.
4
ERK3/MAPK6 controls IL-8 production and chemotaxis.ERK3/MAPK6 控制 IL-8 的产生和趋化作用。
Elife. 2020 Apr 21;9:e52511. doi: 10.7554/eLife.52511.
5
The adrenergic-induced ERK3 pathway drives lipolysis and suppresses energy dissipation.肾上腺素能诱导的 ERK3 通路促进脂肪分解并抑制能量耗散。
Genes Dev. 2020 Apr 1;34(7-8):495-510. doi: 10.1101/gad.333617.119. Epub 2020 Mar 5.
6
Control of actin dynamics during cell motility.细胞运动过程中肌动蛋白动力学的调控。
F1000Res. 2019 Nov 25;8. doi: 10.12688/f1000research.18669.1. eCollection 2019.
7
Filopodia Quantification Using FiloQuant.使用FiloQuant进行丝状伪足定量分析。
Methods Mol Biol. 2019;2040:359-373. doi: 10.1007/978-1-4939-9686-5_16.
8
The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness.非典型 MAPK ERK3 可有效抑制黑素瘤细胞的生长和侵袭。
J Cell Physiol. 2019 Aug;234(8):13220-13232. doi: 10.1002/jcp.27994. Epub 2018 Dec 19.
9
Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.ERK3 的激活环磷酸化对于其激酶活性和促进肺癌细胞侵袭性的能力非常重要。
J Biol Chem. 2018 Oct 19;293(42):16193-16205. doi: 10.1074/jbc.RA118.003699. Epub 2018 Aug 30.
10
Conformational changes in Arp2/3 complex induced by ATP, WASp-VCA, and actin filaments.ATP、WASp-VCA 和肌动蛋白丝诱导的 Arp2/3 复合物构象变化。
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8642-E8651. doi: 10.1073/pnas.1717594115. Epub 2018 Aug 27.